Parkside Financial Bank & Trust Eagle Pharmaceuticals, Inc. Transaction History

Parkside Financial Bank & Trust

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$26.42 - $47.12 $317 - $565	-12 Reduced 14.81%	69 $2,000
Q2 2022 Jul 13, 2022	BUY	$41.26 - $51.35 $2,104 - $2,618	51 Added 170.0%	81 $4,000
Q1 2022 May 13, 2022	SELL	$44.58 - $52.6 $1,471 - $1,735	-33 Reduced 52.38%	30 $1,000
Q3 2021 Oct 29, 2021	BUY	$43.79 - $55.78 $2,627 - $3,346	60 Added 2000.0%	63 $4,000
Q2 2021 Aug 06, 2021	SELL	$36.86 - $44.5 $1,584 - $1,913	-43 Reduced 93.48%	3 $0
Q4 2020 Feb 09, 2021	BUY	$41.72 - $51.34 $959 - $1,180	23 Added 100.0%	46 $2,000
Q3 2020 Nov 06, 2020	BUY	$37.02 - $51.28 $851 - $1,179	23 New	23 $1,000
Q2 2020 Aug 10, 2020	SELL	$43.24 - $55.02 $389 - $495	-9 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$34.37 - $60.07 $137 - $240	-4 Reduced 30.77%	9 $0
Q1 2019 May 01, 2019	BUY	$38.66 - $51.82 $38 - $51	1 Added 8.33%	13 $1,000
Q4 2018 Jan 31, 2019	BUY	$36.72 - $67.73 $146 - $270	4 Added 50.0%	12 $0
Q2 2018 Aug 03, 2018	BUY	$51.25 - $76.62 $153 - $229	3 Added 60.0%	8 $1,000
Q3 2017 Oct 27, 2017	BUY	$46.62 - $60.36 $233 - $301	5	5 $0

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Parkside Financial Bank & Trust with notifications on news.